Department of Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Michael E. DeBakey Veterans Administration Medical Center, Houston, Texas, USA.
Clin Microbiol Rev. 2022 Dec 21;35(4):e0001522. doi: 10.1128/cmr.00015-22. Epub 2022 Sep 27.
All modern advances notwithstanding, pneumonia remains a common infection with substantial morbidity and mortality. Understanding of the etiology of pneumonia continues to evolve as new techniques enable identification of already known organisms and as new organisms emerge. We now review the etiology of pneumonia (at present often called "community-acquired pneumonia") beginning with classic bacteriologic techniques, which identified Streptococcus pneumoniae as the overwhelmingly common cause, to more modern bacteriologic studies, which emphasize Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, , Pseudomonas, and normal respiratory flora. Urine antigen detection is useful in identifying and pneumococcus. The low yield of bacteria in recent studies is due to the failure to obtain valid sputum samples before antibiotics are administered. The use of high-quality sputum specimens enables identification of recognized ("typical") bacterial pathogens as well as a role for commensal bacteria ("normal respiratory flora"). Nucleic acid amplification technology for viruses has revolutionized diagnosis, showing the importance of viral pneumonia leading to hospitalization with or without coinfecting bacterial organisms. Quantitative PCR study of sputum is in its early stages of application, but regular detection of high counts of bacterial DNA from organisms that are not seen on Gram stain or grown in quantitative culture presents a therapeutic dilemma. This finding may reflect the host microbiome of the respiratory tract, in which case treatment may not need to be given for them. Finally, host transcriptional signatures might enable clinicians to distinguish between viral and bacterial pneumonia, an important practical consideration.
尽管所有现代技术都取得了进步,但肺炎仍然是一种常见的感染病,具有相当高的发病率和死亡率。随着新技术能够识别已知的病原体,以及新的病原体不断出现,人们对肺炎的病因的理解仍在不断发展。我们现在回顾肺炎(目前通常称为“社区获得性肺炎”)的病因,首先从经典的细菌学技术开始,这些技术确定了肺炎链球菌是最常见的病原体,然后介绍更现代的细菌学研究,这些研究强调了流感嗜血杆菌、金黄色葡萄球菌、卡他莫拉菌、铜绿假单胞菌和正常呼吸道菌群。尿抗原检测可用于识别肺炎链球菌和肺炎支原体。在最近的研究中,细菌的检出率较低,这是由于在使用抗生素之前未能获得有效的痰液样本。使用高质量的痰液标本可以识别已识别的(“典型”)细菌病原体,以及共生细菌(“正常呼吸道菌群”)的作用。病毒的核酸扩增技术极大地推动了诊断,表明病毒性肺炎导致住院的重要性,无论是否合并有细菌感染。痰液定量 PCR 研究仍处于应用的早期阶段,但常规检测到大量不在革兰氏染色或定量培养中见到的细菌 DNA 计数会带来治疗上的困境。这一发现可能反映了呼吸道的宿主微生物组,在这种情况下,可能不需要对其进行治疗。最后,宿主转录特征可能使临床医生能够区分病毒性和细菌性肺炎,这是一个重要的实际考虑因素。